Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $1.207B (100.0% shares, 0.0% debt)

Holdings (30)

BMRN BIOMARIN PHARMACEUTICAL INC 14.8%
Value $178M Shares 1,831,035 Share Price $97.24 * Est. Cost/Share $83.16 Unrealized @ Report Date +24.7%
— REVANCE THERAPEUTICS INC 14.1%
Value $170M Shares 5,270,209 Share Price $32.21 Est. Cost/Share $21.40 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 11.6%
Value $141M Shares 627,514 Share Price $223.96 * Est. Cost/Share $89.23 Unrealized @ Report Date +176.3%
FOLD AMICUS THERAPEUTICS INC 9.7%
Value $117M Shares 10,524,022 Share Price $11.09 * Est. Cost/Share $9.63 Unrealized @ Report Date +28.1%
BIIB BIOGEN INC 8.8%
Value $106M Shares 381,282 Share Price $278.03 Est. Cost/Share $264.98 Unrealized @ Report Date +4.4%
INSM INSMED INC 8.3%
Value $100M Shares 5,889,491 Share Price $17.05 * Est. Cost/Share $17.79 Unrealized @ Report Date +9.2%
STAA STAAR SURGICAL CO 7.1%
Value $86.16M Shares 1,347,322 Share Price $63.95 * Est. Cost/Share $23.48 Unrealized @ Report Date +177.9%
PRTA PROTHENA CORP PLC 6.7%
Value $80.64M Shares 1,663,777 Share Price $48.47 * Est. Cost/Share $21.46 Unrealized @ Report Date +146.2%
ACAD ACADIA PHARMACEUTICALS INC 3.8%
Value $45.28M Shares 2,405,793 Share Price $18.82 Est. Cost/Share $28.41 Unrealized @ Report Date -33.0%
— SAGE THERAPEUTICS INC 3.0%
Value $36.07M Shares 859,517 Share Price $41.96 Est. Cost/Share $46.62 Unrealized @ Report Date —
EHTH EHEALTH INC 2.1%
Value $25.17M Shares 2,689,379 Share Price $9.36 * Est. Cost/Share $38.69 Unrealized @ Report Date -79.7%
ALGN ALIGN TECHNOLOGY INC 2.1%
Value $24.93M Shares 74,605 Share Price $334.14 * Est. Cost/Share $149.18 Unrealized @ Report Date +97.8%
— KARYOPHARM THERAPEUTICS INC 1.8%
Value $22.08M Shares 5,675,876 Share Price $3.89 Est. Cost/Share $16.36 Unrealized @ Report Date —
ALKS ALKERMES PLC 1.4%
Value $17.01M Shares 603,400 Share Price $28.19 * Est. Cost/Share $22.36 Unrealized @ Report Date +21.8%
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value $12.94M Shares 612,600 Share Price $21.12 * Est. Cost/Share $16.84 Unrealized @ Report Date +47.7%
— PROVENTION BIO INC 0.8%
Value $9.418M Shares 390,800 Share Price $24.10 Est. Cost/Share $4.50 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 0.8%
Value $9.383M Shares 431,224 Share Price $21.76 * Est. Cost/Share $19.06 Unrealized @ Report Date +27.5%
GOSS GOSSAMER BIO INC 0.4%
Value $4.366M Shares 3,465,152 Share Price $1.26 * Est. Cost/Share $2.02 Unrealized @ Report Date -5.4%
CYTK CYTOKINETICS INC 0.3%
Value $3.931M Shares 111,717 Share Price $35.19 * Est. Cost/Share $6.71 Unrealized @ Report Date +507.7%
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value $3.735M Shares 166,069 Share Price $22.49 * Est. Cost/Share $23.56 Unrealized @ Report Date -9.8%
VNDA VANDA PHARMACEUTICALS INC 0.3%
Value $3.278M Shares 482,697 Share Price $6.79 * Est. Cost/Share $11.21 Unrealized @ Report Date -37.3%
— KEZAR LIFE SCIENCES INC 0.2%
Value $2.054M Shares 656,200 Share Price $3.13 Est. Cost/Share $5.16 Unrealized @ Report Date —
NVCR NOVOCURE LTD 0.2%
Value $1.972M Shares 32,790 Share Price $60.14 * Est. Cost/Share $79.91 Unrealized @ Report Date 0.0%
— GRITSTONE ONCOLOGY INC 0.2%
Value $1.852M Shares 666,127 Share Price $2.78 Est. Cost/Share $9.42 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $1.597M Shares 160,800 Share Price $9.93 * Est. Cost/Share $7.10 Unrealized @ Report Date -0.4%
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.554M Shares 64,700 Share Price $24.02 * Est. Cost/Share $15.56 Unrealized @ Report Date +46.5%
RLMD RELMADA THERAPEUTICS INC 0.1%
Value $1.225M Shares 542,100 Share Price $2.26 * Est. Cost/Share $3.45 Unrealized @ Report Date 0.0%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $445K Shares 27,100 Share Price $16.42 * Est. Cost/Share $39.74 Unrealized @ Report Date -65.0%
— PEAK BIO INC 0.0%
Value $314K Shares 497,528 Share Price $0.63 Est. Cost/Share $4.06 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $226K Shares 24,500 Share Price $9.24 Est. Cost/Share $27.01 Unrealized @ Report Date -65.9%